2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of …

E Arbelo, A Protonotarios, JR Gimeno… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

The current role of next-generation DNA sequencing in routine care of patients with hereditary cardiovascular conditions: a viewpoint paper of the European Society of …

J Mogensen, JP van Tintelen, S Fokstuen… - European heart …, 2015 - academic.oup.com
Cardiomyopathies, arrhythmic syndromes, aortopathies, and other cardiovascular diseases
with Mendelian inheritance are relatively frequent conditions for which genetic testing is …

Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients

L Monserrat, PM Elliott, JR Gimeno, S Sharma… - Journal of the American …, 2003 - jacc.org
Objectives: The aim of this study was to examine the characteristics of non-sustained
ventricular tachycardia (NSVT) episodes during Holter monitoring and to determine their …

Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy

PM Elliott, JR Gimeno, MT Tomé, J Shah… - European heart …, 2006 - academic.oup.com
Aims Left ventricular outflow tract obstruction (LVOTO) is associated with reduced survival in
patients with hypertrophic cardiomyopathy (HCM). The influence of LVOTO on survival from …

[HTML][HTML] Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations

J Mogensen, T Kubo, M Duque, W Uribe… - The Journal of …, 2003 - Am Soc Clin Investig
Restrictive cardiomyopathy (RCM) is an uncommon heart muscle disorder characterized by
impaired filling of the ventricles with reduced volume in the presence of normal or near …

Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria

MS Hamid, M Norman, A Quraishi, S Firoozi… - Journal of the American …, 2002 - jacc.org
Objectives: We sought to ascertain the prevalence and mode of expression of familial
disease in a consecutive series of patients with arrhythmogenic right ventricular …

Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy

PM Elliott, JR Gimeno, R Thaman, J Shah, D Ward… - Heart, 2006 - heart.bmj.com
Objective: To determine the range of survival rates of patients with hypertrophic
cardiomyopathy (HCM) by comparing and contrasting the natural history of a cohort of …

Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy

G Luxán, JC Casanova, B Martínez-Poveda… - Nature medicine, 2013 - nature.com
Left ventricular noncompaction (LVNC) causes prominent ventricular trabeculations and
reduces cardiac systolic function. The clinical presentation of LVNC ranges from …

Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype

T Kubo, JR Gimeno, A Bahl, U Steffensen… - Journal of the American …, 2007 - jacc.org
Objectives: The purpose of this study was to determine the prevalence, clinical significance,
and genetic basis of hypertrophic cardiomyopathy (HCM) with “restrictive phenotype” …

Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility

J Barc, R Tadros, C Glinge, DY Chiang, M Jouni… - Nature …, 2022 - nature.com
Brugada syndrome (BrS) is a cardiac arrhythmia disorder associated with sudden death in
young adults. With the exception of SCN5A, encoding the cardiac sodium channel NaV1. 5 …